Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 9/20 | 0.81 |
| ▸ | IL1B | P01584 | 2/20 | 0.72 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 9/20 | 0.44 |
| ▸ | GZMB | P10144 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10199480 | 0.91 | CASP1 (0.79) | CASP1IL1BMMEACELCK | |
| SCHEMBL10199466 | 0.90 | CASP1 (0.82) | CASP1IL1BMMEACELCK | |
| SCHEMBL645750 | 0.90 | CASP1 (1.00) | CASP1IL1BMMEACELCK | |
| SCHEMBL8248977 | 0.90 | CASP1 (1.00) | CASP1IL1BMMEACELCK | |
| SCHEMBL2218994 | 0.90 | CASP1 (1.00) | CASP1IL1BMMEACELCK | |
| SCHEMBL10199526 | 0.89 | CASP1 (0.86) | CASP1IL1BMMEACELCK | |
| SCHEMBL10199711 | 0.89 | CASP1 (0.91) | CASP1IL1BMMEACELCK | |
| SCHEMBL10200454 | 0.87 | CASP1 (0.87) | CASP1IL1BMMEACELCK | |
| SCHEMBL10199785 | 0.87 | CASP1 (0.87) | CASP1IL1BMMEACELCK | |
| SCHEMBL10199422 | 0.87 | CASP1 (0.86) | CASP1IL1BMMEACELCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423840-B1 | FORMING N-ACYLAMINO COMPOUND | VERTEX PHARMACEUTICALS INCORPORATED | 2002-07-23 | — | — | US | disclosed |
| US-6204261-B1 | Inhibitors of interleukin-1β Converting enzyme inhibitors | VERTEX PHARMACEUTICALS INCORPORATED | 2001-03-20 | — | — | US | disclosed |